WU Shan, ZHANG Yeye, GUO Haixia, LIU Junjie, SUN Zhiguo, ZHONG Yanqiang, ZOU Hao. A comparison study of synthesizing methods of thiolated doxorubicin[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 428-433. doi: 10.3969/j.issn.1006-0111.2014.06.008
| Citation:
|
WU Shan, ZHANG Yeye, GUO Haixia, LIU Junjie, SUN Zhiguo, ZHONG Yanqiang, ZOU Hao. A comparison study of synthesizing methods of thiolated doxorubicin[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 428-433. doi: 10.3969/j.issn.1006-0111.2014.06.008
|
A comparison study of synthesizing methods of thiolated doxorubicin
- 1.
Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
- 2.
NO.266 Hospital of PLA, Chengde 067000, China
- Received Date: 2014-08-02
- Rev Recd Date:
2014-10-13
-
Abstract
Objective To investigate the optimal method for synthesizing thiolated doxorubicin. Methods Thiolated doxorubicin was synthesized through two different methods. Doxorubicin was reacted with 2-iminothiolane (2-IT) and S-acetylthioglycolic acid N-hydroxysuccinimide ester (SATA),respectively. The synthesized thiolated doxorubicin was further characterized by HPLC and MS-ESI techniques. Several factors including molar ratios as well as reaction time were evaluated. Results The results showed that thiolated doxorubicin could be synthesized via both of the two methods successfully. Thiolated doxorubicin could be stable when doxorubicin was reacted with SATA. But the crude thiolated doxorubicin could be cyclized easily when doxorubicin was reacted with 2-IT. Conclusion Thiolated doxorubicin prepared with SATA is more feasible than that with 2-IT.
-
References
|
[1]
|
Li PY, Lai PS, Hung WC, et al. Poly(l-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells[J].Biomacromolecules 2010,11(10):2576-2582. |
|
[2]
|
Kibria G, Hatakeyama H, Harashima H.Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system[J].Arch Pharm Res, 2014, 37(1): 4-15. |
|
[3]
|
Thierry AR, Vige D, Coughlin SS, et al. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes[J].FASEB J, 1993,7(6):572-579. |
|
[4]
|
Kumar SA, Peter YA, Nadeau JL. Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin[J].Nanotechnology,2008,10(49):495101. |
|
[5]
|
Barraud L, Merle P, Soma E, et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo[J].J Hepatol 2005,42(5):736-743. |
|
[6]
|
Ma P, Mumper RJ. Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review[J].Nano Today,2013,8(3):313-331. |
|
[7]
|
Wang X, Cai X, Hu J, et al. Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles[J].J Am Chem Soc 2013,135(26):9805-9810. |
|
[8]
|
Gu YJ, Cheng J, Man CW, et al. Gold-doxorubicin nanoconjugates for overcoming multidrug resistance[J]. Nanomedicine, 2012,8(2):204-211. |
-
-
Proportional views
-
DownLoad: